Related Experiment Video
Updated: May 7, 2025

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
Published on: December 15, 2023
Technology Enhanced Multidisciplinary Cancer Conferences in Gynecologic Oncology: Impact on Quality and Education
Opuruiche Ibekwe1, Amma F Agyemang2,3, Carmelo Gaudioso4
1Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, Elm and Carlton Sts, Buffalo, NY, 14263, USA. opuruiche.ibekwe@roswellpark.org.
None:
Multidisciplinary cancer conferences (MCCs) improve patient outcomes. Our goals were to investigate the impact of a technology platform, navify® Clinical Hub for Tumor Boards (nCH) on the quality and educational value of gynecologic oncology MCCs. We conducted a prospective, mixed methods study of the gynecologic oncology MCC at a comprehensive cancer center from 2020 to 2023. Using a validated observational tool, we assessed the quality of case presentation and discussion (as measured by a mean composite score) before and after the introduction of nCH. We also evaluated compliance of care plans with national guidelines, changes in care plans, and concordance of treatment received with MCC recommendations. Surveys and interviews were used to evaluate the educational value of the MCCs. Analyses were conducted using SAS v9.4 (Cary, NC) and Dedoose v9.0.17, (Los Angeles, CA). Pre- and post-nCH cohorts consisted of 49 and 60 patients, respectively. When comparing both cohorts, there was a difference in the mean composite score (50.57 vs 54.11; p = 0.016). Care plans were changed by the MCC in approximately 12% of cases, and MCC recommendations were 93-96% concordant with treatment received, but no statistically significant differences were observed. Additionally, MCC recommendations were 100% compliant with guidelines. Interviews of MCC participants revealed that the post-nCH presentation was more concise and structured. Despite limited use of some nCH features, GYN fellows reported a high educational value of the MCC. nCH improved the quality of the gynecologic oncology MCC and the educational experience of trainees.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Current Trends in Nursing II
Targeted Cancer Therapies
There are several types of targeted therapies against...

